Ulcerative Colitis Clinical Trials in Chicago

Showing 681-700 of 806 trials

Efficacy of Gralise® for Chronic Pelvic Pain

NCT01678911

This study is done to investigate the pain relieving effects of the study drug Gralise (a novel long acting gabapentinoid) for people who experience chronic pelvic pain. Subjects with Irritable Bowel Syndrome, Interstitial Cystitis, Ulcerative Colitis, and Prostatitis will be recruited. The purpose of this research is to look at how the study drug can be used to benefit people who experience this type of pain. This is a phase IV study done to study the safety and effectiveness of the drug. At this point the drug has been approved by the Food and Drug Administration and has been reported to be well tolerated and effective in the treatment of various chronic pain conditions, particularly in neuropathic pain. About 36 subjects will take part in this study.

Irritable Bowel SyndromeUlcerative ColitisInterstitial Cystitis+2 more

Shirley Ryan AbilityLab11 participantsStarted Aug 2012

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

NCT00073021

This study is a prospective clinical study to evaluate the safety and efficacy of two different doses of Asacol for the treatment of moderately active ulcerative colitis. In addition, a new tablet formulation will be evaluated at one of the two doses.

Ulcerative Colitis

Warner Chilcott386 participantsStarted Sep 2000

Scottsdale, Arizona, United States • Anaheim, California, United States • Los Angeles, California, United States +54 more locations

Efficacy of Gralise® for Chronic Pelvic Pain

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

Ulcerative Colitis Trials in Other Cities

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

Dose Ranging Study

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NVA237 BID Versus Placebo Twelve-week Efficacy Study

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

Evaluation of the Spectra Optia PMN Cell Collection Procedure

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

MANAGE Automated Glucose Monitoring

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

Other Conditions in Chicago